Cargando…

Molecular and Clinical Characterization of a Novel Prognostic and Immunologic Biomarker GPSM3 in Low-Grade Gliomas

Background: as the most common malignancy of the central nervous system, low-grade glioma (LGG) patients suffered a poor prognosis. Tumor microenvironment, especially immune components, plays an important role in the progression of tumors. Thus, it is critical to explore the key immune-related genes...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Ming, Jia, Jiaoying, Cui, Yan, Peng, Yong, Jiang, Yugang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8615402/ https://www.ncbi.nlm.nih.gov/pubmed/34827528 http://dx.doi.org/10.3390/brainsci11111529

Ejemplares similares

GPSM2 Serves as an Independent Prognostic Biomarker for Liver Cancer Survival
por: Yang, Dingquan, et al.
Publicado: (2020)

Immunological and prognostic analysis of PSENEN in low-grade gliomas: An immune infiltration-related prognostic biomarker
por: Chen, Kaijie, et al.
Publicado: (2022)

Molecular and Clinical Characterization of a Novel Prognostic and Immunologic Biomarker FAM111A in Diffuse Lower-Grade Glioma
por: Ji, Xiaoshuai, et al.
Publicado: (2020)

MiR-150-3p targets SP1 and suppresses the growth of glioma cells
por: Tan, Zhigang, et al.
Publicado: (2018)

OSlgg: An Online Prognostic Biomarker Analysis Tool for Low-Grade Glioma
por: An, Yang, et al.
Publicado: (2020)

Identifying GPSM Family Members as Potential Biomarkers in Breast Cancer: A Comprehensive Bioinformatics Analysis
por: Dang, Huy-Hoang, et al.
Publicado: (2021)

CD73-positive extracellular vesicles promote glioblastoma immunosuppression by inhibiting T-cell clonal expansion
por: Wang, Ming, et al.
Publicado: (2021)

Downregulation of GPSM2 is associated with primary resistance to paclitaxel in breast cancer
por: Zhang, Zhe, et al.
Publicado: (2020)

Comprehensive Bioinformatics Analysis of mRNA Expression Profiles and Identification of a miRNA–mRNA Network Associated with the Pathogenesis of Low-Grade Gliomas
por: Wang, Ming, et al.
Publicado: (2021)

New prognostic biomarker CMTM3 in low grade glioma and its immune infiltration
por: Li, Shoubin, et al.
Publicado: (2022)

PTPRN Serves as a Prognostic Biomarker and Correlated with Immune Infiltrates in Low Grade Glioma
por: Li, Peng, et al.
Publicado: (2022)

IRF7 as an Immune-Related Prognostic Biomarker and Associated with Tumor Microenvironment in Low-Grade Glioma
por: Peng, Shijun, et al.
Publicado: (2021)

GPSM1 impairs metabolic homeostasis by controlling a pro-inflammatory pathway in macrophages
por: Yan, Jing, et al.
Publicado: (2022)

A Novel CRISPR/Cas9 Screening Potential Index for Prognostic and Immunological Prediction in Low-Grade Glioma
por: Li, Xiangpan, et al.
Publicado: (2022)

Prognostic Factors of Low-Grade Gliomas in Adults
por: Deacu, Mariana, et al.
Publicado: (2022)

LGG-46. MOLECULAR CHARACTERIZATION OF HEMISPHERIC LOW-GRADE GLIOMAS IN CHILDREN
por: Mišove, Adéla, et al.
Publicado: (2020)

The Prognostic and Immunological Value of Guanylate-Binding Proteins in Lower-Grade Glioma: Potential Markers or Not?
por: Liu, Zhuang, et al.
Publicado: (2021)

LGG-04. Clinical and molecular characterization of metastatic pediatric low grade gliomas
por: Lindsay, Holly, et al.
Publicado: (2022)

METTL21B is a prognostic biomarker and potential therapeutic target in low-grade gliomas
por: Shu, Xin, et al.
Publicado: (2021)

Protective Prognostic Biomarkers Negatively Correlated with Macrophage M2 Infiltration in Low-Grade Glioma
por: Zhu, Yunyang, et al.
Publicado: (2022)

Localization of GPSM2 in the Nucleus of Invasive Breast Cancer Cells Indicates a Poor Prognosis
por: Deng, Mingming, et al.
Publicado: (2020)

Interaction between Discs large and Pins/LGN/GPSM2: a comparison across species
por: Schiller, Emily A., et al.
Publicado: (2021)

Prognostic value of magnetic resonance imaging features in low-grade gliomas
por: Deng, Liang, et al.
Publicado: (2019)

Arachidonate lipoxygenases 5 is a novel prognostic biomarker and correlates with high tumor immune infiltration in low-grade glioma
por: Pan, Rui-han, et al.
Publicado: (2023)

Study on the Prognostic Values of Dynactin Genes in Low-Grade Glioma
por: Su, Xiaotao, et al.
Publicado: (2021)

High STK40 Expression as an Independent Prognostic Biomarker and Correlated with Immune Infiltrates in Low-Grade Gliomas
por: Pan, Heyue, et al.
Publicado: (2021)

S100A gene family: immune-related prognostic biomarkers and therapeutic targets for low-grade glioma
por: Zhang, Yu, et al.
Publicado: (2021)

Circulating miRNAs as Diagnostic and Prognostic Biomarkers in High-Grade Gliomas
por: Wu, Jianing, et al.
Publicado: (2022)

Pediatric low-grade glioma in the era of molecular diagnostics
por: Ryall, Scott, et al.
Publicado: (2020)

Genetic variations in GPSM3 associated with protection from rheumatoid arthritis affect its transcript abundance
por: Gall, BJ, et al.
Publicado: (2016)

RGS12 polarizes the GPSM2-GNAI complex to organize and elongate stereocilia in sensory hair cells
por: Akturk, Anil, et al.
Publicado: (2022)

Correlation between ITGB2 expression and clinical characterization of glioma and the prognostic significance of its methylation in low-grade glioma(LGG)
por: Liu, He, et al.
Publicado: (2023)

Activity of Wnt/PCP Regulation Pathway Classifies Patients of Low-Grade Glioma Into Molecularly Distinct Subgroups With Prognostic Difference
por: Zhang, Meng, et al.
Publicado: (2021)

Classification of diffuse lower‐grade glioma based on immunological profiling
por: Wu, Fan, et al.
Publicado: (2020)

Characterization and prognostic significance of alternative splicing events in lower‐grade diffuse gliomas
por: Zhao, Zheng, et al.
Publicado: (2020)

Ferroptosis-related gene MTF-1 as a novel prognostic biomarker in low-grade glioma and its correlation with immune infiltration
por: Li, Huaixu, et al.
Publicado: (2023)

NCAPG2 Is a Novel Prognostic Biomarker and Promotes Cancer Stem Cell Maintenance in Low-Grade Glioma
por: Ren, Wenjun, et al.
Publicado: (2022)

Prokineticins as a Prognostic Biomarker for Low-Grade Gliomas: A Study Based on The Cancer Genome Atlas Data
por: Zhong, Junqing, et al.
Publicado: (2022)

Prognostic significance of ARL9 and its methylation in low-grade glioma
por: Tan, Yutang, et al.
Publicado: (2020)

Establishment of an Endocytosis-Related Prognostic Signature for Patients With Low-Grade Glioma
por: Wang, Dawei, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_0u3qg2md3vj5h38m4hrfovaqin